Streamlining R&D permission for substantial amendments to oncology clinical trials at an NHS site: a case study
Crossref DOI link: https://doi.org/10.1186/1745-6215-16-S2-P190
Published Online: 2015-11-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
I'Anson, David
Smith, Amy
Aslam, Natasha
Gyertson, Kylie
Sidhu, Rajinder
Agathou, Smaragda
Gill, Ashparan
Whelan, Jeremy
Text and Data Mining valid from 2015-11-16
Version of Record valid from 2015-11-16
Article History
First Online: 16 November 2015